We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
631
Increased
3,220
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLTK icon
3901
Playtika
PLTK
$957M
$21K ﹤0.01%
2,302
-49,556
-96% -$571K
SBEV icon
3902
Splash Beverage Group
SBEV
$2.55M
$21K ﹤0.01%
98
+86
+717% +$32.6K
SFST icon
3903
Southern First Bancshares
SFST
$608M
$21K ﹤0.01%
497
-297
-37% -$13.1K
FIRY
3904
Firy Inc
FIRY
$156M
$21K ﹤0.01%
1,040
-1,080
-51% -$30.4K
SNTI icon
3905
Senti Biosciences Holdings
SNTI
$14M
$21K ﹤0.01%
945
+822
+668% +$16.2K
SVT
3906
DELISTED
Servotronics
SVT
$21K ﹤0.01%
+1,831
New +$20.5K
UONEK icon
3907
Urban One Class D
UONEK
$23.4M
$21K ﹤0.01%
489
-1,175
-71% -$49.6K
VNRX icon
3908
VolitionRx Ltd
VNRX
$6.89M
$21K ﹤0.01%
783
+440
+128% +$16.6K
VONV icon
3909
Vanguard Russell 1000 Value ETF
VONV
$22B
$21K ﹤0.01%
346
-15,782
-98% -$1.04M
VRCA icon
3910
Verrica Pharmaceuticals
VRCA
$85.4M
$21K ﹤0.01%
705
+51
+8% +$1.75K
VVX icon
3911
V2X
VVX
$2.6B
$21K ﹤0.01%
602
-52
-8% -$1.81K
WLK icon
3912
Westlake Corp
WLK
$10.2B
$21K ﹤0.01%
244
+150
+160% +$14.4K
LENZ
3913
LENZ Therapeutics
LENZ
$149M
$21K ﹤0.01%
926
+824
+808% +$19.6K
HEAL
3914
Global X Funds Global X HealthTech ETF
HEAL
$31M
$21K ﹤0.01%
611
+592
+3,116% +$22K
MKFG
3915
DELISTED
Markforged Holding Corporation
MKFG
$21K ﹤0.01%
1,066
+258
+32% +$5.97K
DMTK
3916
DELISTED
DermTech, Inc. Common Stock
DMTK
$21K ﹤0.01%
5,347
+2,617
+96% +$16.1K
ZYNE
3917
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$21K ﹤0.01%
29,146
+27,034
+1,280% +$30.7K
QUOT
3918
DELISTED
Quotient Technology Inc
QUOT
$21K ﹤0.01%
9,149
+6,374
+230% +$15.6K
CPUH.U
3919
DELISTED
Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
CPUH.U
$21K ﹤0.01%
2,089
BSGA
3920
DELISTED
Blue Safari Group Acquisition Corp. Class A Ordinary Share
BSGA
$21K ﹤0.01%
2,032
-42
-2% -$428
PACX
3921
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$21K ﹤0.01%
2,118
-480
-18% -$4.75K
PZN
3922
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$21K ﹤0.01%
2,246
+802
+56% +$7.04K
SWI
3923
DELISTED
SolarWinds Corporation Common Stock
SWI
$21K ﹤0.01%
2,675
-4,225
-61% -$40.5K
LBTYB
3924
DELISTED
Liberty Global plc Class B
LBTYB
$21K ﹤0.01%
1,228
+592
+93% +$10.1K
ARHS icon
3925
Arhaus
ARHS
$1.39B
$20K ﹤0.01%
2,898
-2,893
-50% -$20.6K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 631 new positions and adding to 3,220 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 631 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.